OneMedNet Reports 80% Reduction in Debt Enabling Focus On Growth

Rhea-AI Summary

OneMedNet (NASDAQ:ONMD), an AI-powered Real-World Data company, reported significant financial improvements in Q2 2025. The company achieved an 80% reduction in total liabilities, decreasing from $19.7M to $6.2M, with an additional $1.9M reduction in July 2025.

Key financial highlights include $3.0M net income in Q2 2025, $3.7M raised through private placements, and holdings of 15 BTC valued at $1.6M. Operationally, OneMedNet expanded its provider network to 1,750 sites with access to 136M clinical studies, while enhancing its iRWD™ platform with improved AI capabilities and adding over 5 billion administrative records and claims.

Positive

• Significant debt reduction of 80%, improving balance sheet strength
• Net income of $3.0M in Q2 2025 and $1.1M YTD
• Successful private placement raising $3.7M, including $1.2M from insiders
• Strategic bitcoin holdings of 15 BTC valued at $1.6M
• Network expansion to 1,750 provider sites with access to 136M clinical studies
• Platform enhancement with 5B+ administrative records and claims data

Negative

• Significant portion of net income ($5.0M) came from debt settlements rather than operations
• Reliance on private placements for operational funding

Insights

Financial Restructuring Analyst

OneMedNet's 80% debt reduction transforms balance sheet, creating financial flexibility while achieving profitability through strategic debt settlements.

OneMedNet's dramatic financial transformation stands out as the cornerstone of their Q2 2025 results. The company has executed a comprehensive liability reduction strategy, slashing total liabilities from $19.7 million to approximately $4.3 million through a combination of debt conversions, vendor repayments, and heavily discounted settlements. This 80% reduction in debt burden represents a fundamental shift in the company's financial foundation.

The financial restructuring has delivered immediate bottom-line impact, with discounted debt settlements and conversions generating $5.0 million in other income. This non-operational gain propelled the company to $3.0 million in quarterly net income and $1.1 million for the first half of 2025. While investors should note this profitability stems primarily from financial engineering rather than operational performance, the improved balance sheet creates significant financial flexibility.

The $3.7 million in new private placements, including $1.2 million from insiders, provides working capital to support growth initiatives. Insider participation signals management confidence in the restructured business. The 15 BTC holding ($1.6 million) represents a non-traditional treasury approach that introduces cryptocurrency market exposure to the company's financial profile.

This financial overhaul transforms OneMedNet from a debt-burdened entity to one with significantly improved solvency metrics and operational runway, allowing management to redirect focus from balance sheet concerns to executing their RWD platform growth strategy in a rapidly evolving healthcare data market.

Healthcare Data Analytics Specialist

OneMedNet's operational expansion demonstrates substantial scaling of their iRWD™ platform infrastructure. The addition of 5 billion+ administrative records significantly enhances their data repository with critical health economics and social determinants information – essential elements for comprehensive healthcare analytics beyond pure clinical data.

The provider network expansion to 1,750 sites with access to 136 million clinical studies represents impressive market penetration in the fragmented healthcare data ecosystem. This expanded footprint creates a more valuable data network effect, improving both data diversity and statistical power for research applications.

The company's enhancement of AI-driven de-identification capabilities addresses a critical market need as healthcare organizations struggle with HIPAA compliance while maximizing data utility. Their focus on federated search and multi-modal data integration directly targets the healthcare industry's persistent data silos problem.

OneMedNet is strategically positioning itself at the intersection of healthcare's most valuable asset (clinical data) and the technological capabilities needed to transform that data into actionable insights. Their expanded real-world data infrastructure provides the foundation for AI applications while maintaining regulatory compliance – creating a defensible competitive position in the rapidly growing RWD market that's increasingly essential for pharmaceutical research, clinical decision support, and value-based care initiatives.

MINNEAPOLIS, Aug. 14, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leader in AI-powered Real-World Data (RWD), announced its financial results for the second quarter ended June 30, 2025, including its significantly improved balance sheet.

Second Quarter and First Half 2025 Financial Highlights

• Improved Balance Sheet: Due to the combination of debt conversions, vendor repayments, and highly discounted debt settlements, total liabilities have been reduced from $19.7 million as of December 31, 2024, to $6.2 million as of June 30, 2025, a reduction of approximately $13.5 million. Additional discounted debt settlements in July 2025 further reduced liabilities by $1.9 million, resulting in aggregate reductions in liabilities by approximately 80% since December 31, 2024.  
• Net Income: The combination of discounted debt settlements and debt conversions resulted in other income of $5.0 million in the second quarter of 2025 which contributed to overall net income of $3.0 million for the second quarter and $1.1 million of net income through June 30, 2025.
• Private Placements: Successfully completed $3.7 million in private placements of Company securities, including $1.2 million of this investment from insiders, providing capital to accelerate sales execution, expand the iRWD™ platform, and support customer acquisition and operations.
• Bitcoin Holdings: As of June 30, 2025, the Company maintained a strategic digital asset position of 15 BTC with a value of $1.6 million.

Second Quarter Operational Highlights

• Expanded with 5 Billion+ Administrative Records and Claims, enhancing the OneMedNet Network & Platform with deep health economics and social determinants insights.
• Expanded provider network to 1,750 sites, now offering access to 136M clinical studies.
• Enhanced iRWD™ platform capabilities to improve AI-driven de-identification, federated search, and multi-modal data integration.
  

“We are focused on our strategy, and the second quarter marked an important milestone for OneMedNet, with the Company moving forward with a strong sales funnel, a scalable proven platform and an improved balance sheet. The combination of reduced debt, and strategic capital infusions enables us to focus on strategic opportunities to deliver long-term value to our customers, partners, and shareholders,” says Aaron Green, CEO & President OneMedNet.

About OneMedNet Corporation

OneMedNet is revolutionizing how the world unlocks Real-World Data (RWD), harnessing the untapped potential of over 1,750 healthcare sites through its iRWD™ platform. This isn’t just data—it’s the lifeblood of innovation, from de-identified medical imaging to electronic health records, fueling breakthroughs for drugmakers, medical device pioneers, and AI visionaries. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that redefine patient care and power the next wave of healthcare disruption.

Beyond healthcare OneMedNet’s proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking endless possibilities—rigorously testing production system upgrades, de-risking complex projects, and securely sharing sensitive data by stripping out personal information. Learn more at www.onemednet.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements. All statements other than statements of historical facts contained in this press release are forward-looking statements. We base these forward-looking statements on our current expectations and projections about future events, which we derive from the information presently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; risks inherent with investing in Bitcoin, including Bitcoin’s volatility; and our ability to implement our Bitcoin treasury strategy and its effects on our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this press release to conform these statements to actual results or to changes in our expectations.

OneMedNet Contacts:
Michael Wong, VP Marketing
Email: michael.wong@onemednet.com

SOURCE: ONEMEDNET CORPORATION

FAQ

How much did OneMedNet (ONMD) reduce its debt in Q2 2025?

OneMedNet reduced its total liabilities by approximately 80%, from $19.7M to $6.2M as of June 30, 2025, with an additional $1.9M reduction in July 2025.

What was OneMedNet's (ONMD) net income for Q2 2025?

OneMedNet reported net income of $3.0M for Q2 2025 and $1.1M through June 30, 2025, largely driven by $5.0M in other income from discounted debt settlements.

How much capital did OneMedNet (ONMD) raise in private placements?

OneMedNet successfully raised $3.7M through private placements, with $1.2M coming from insider investments.

What is the size of OneMedNet's (ONMD) provider network as of Q2 2025?

OneMedNet's provider network expanded to 1,750 sites with access to 136M clinical studies.

How many Bitcoin does OneMedNet (ONMD) hold and what is their value?

As of June 30, 2025, OneMedNet held 15 BTC valued at $1.6M as part of its strategic digital asset position.